These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7843555)

  • 1. [Shifts in the human immune system in various disorders as a result of use of immunomodulators].
    Zemskov AM; Zemskov VM; Zoloedov VI
    Fiziol Cheloveka; 1994; 20(5):91-8. PubMed ID: 7843555
    [No Abstract]   [Full Text] [Related]  

  • 2. [The pharmacological correction of immune homeostatic disorders in servicemen].
    Zabrodskiĭ PF
    Voen Med Zh; 1994 Sep; (9):49-52. PubMed ID: 7825289
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacotherapy of immune diseases].
    Baenkler HW
    Med Monatsschr Pharm; 1991 Dec; 14(12):356-61. PubMed ID: 1784262
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunomodulators and some aspects of their clinical use].
    Khaitov RM; Pinegin BV
    Klin Med (Mosk); 1996; 74(8):7-12. PubMed ID: 9036219
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppression or immunostimulation or both?
    James DG
    Minerva Med; 1978 Aug; 69(38):2637-42. PubMed ID: 714262
    [No Abstract]   [Full Text] [Related]  

  • 6. [Syndrome of secondary immunodeficiency: pathogenesis and approaches to treatment].
    Moskalets OV; Paleev FN; Kotova AA; Naumova TE; Suchkov SV
    Klin Med (Mosk); 2002; 80(11):18-23. PubMed ID: 12516334
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunomodulators, immunostimulants, and immunotherapies in small animal veterinary medicine.
    Thacker EL
    Vet Clin North Am Small Anim Pract; 2010 May; 40(3):473-83. PubMed ID: 20471530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulators: a brave new world.
    Ballas ZK
    J Allergy Clin Immunol; 2008 Feb; 121(2):331-3. PubMed ID: 18269924
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40.
    Sugamura K; Ishii N; Weinberg AD
    Nat Rev Immunol; 2004 Jun; 4(6):420-31. PubMed ID: 15173831
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanism of action and clinical effectiveness of immunomodulator glucosaminylmuramyl dipeptide (licopide)].
    Ivanov VT; Andronova TM; Nesmeianov VA; Pinegin BV; Ledger P; Bomford R; Khaitov RM
    Klin Med (Mosk); 1997; 75(3):11-5. PubMed ID: 9229604
    [No Abstract]   [Full Text] [Related]  

  • 11. [Functional disturbances of the immune system in rheumatic diseases and their dynamics in the context of pathogenetic therapy].
    Timofeev VT; Naokhin VN; Poriadin GV; Goloviznin MV
    Patol Fiziol Eksp Ter; 1998; (1):13-6. PubMed ID: 9542398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The complement system and clinical effects of its disorders].
    Siegert CE; van Es LA; Daha MR
    Ned Tijdschr Geneeskd; 1996 Nov; 140(46):2268-73. PubMed ID: 8984378
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders.
    Rook GA; Adams V; Hunt J; Palmer R; Martinelli R; Brunet LR
    Springer Semin Immunopathol; 2004 Feb; 25(3-4):237-55. PubMed ID: 15007629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for modulating TNF alpha in immune and inflammatory disease.
    Baugh JA; Bucala R
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):635-50. PubMed ID: 12825458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological aspects of aging and malnutrition: consequences and intervention with nutritional immunomodulators.
    Heuser MD; Adler WH
    Clin Geriatr Med; 1997 Nov; 13(4):697-715. PubMed ID: 9354750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The characteristics of the immunogenesis and immunocorrection of diabetes mellitus].
    Galenok VA; Zhuk EA
    Ter Arkh; 1995; 67(10):7-12. PubMed ID: 8779114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the validity of animal models for research into therapies for immune-based disorders.
    't Hart BA; Amor S; Jonker M
    Drug Discov Today; 2004 Jun; 9(12):517-24. PubMed ID: 15183159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immunological disorders in nonspecific lung diseases and the principles for their correction (a lecture)].
    Nikitin AV; Zemskov AM
    Probl Tuberk; 1993; (1):29-32. PubMed ID: 8327434
    [No Abstract]   [Full Text] [Related]  

  • 19. [The state of immune system and effects of current therapy and immunomodulators].
    Tsimmerman IaS; Mikhaleva EN
    Klin Med (Mosk); 2003; 81(1):40-4. PubMed ID: 12650095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seventh interscience world conference on inflammation, antirheumatic, analgesic immunomodulators, cardiovascular diseases and inflammation: WHO activities.
    Nordet P
    Int J Tissue React; 1998; 20(1):1-2. PubMed ID: 9561440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.